| 239.39 -0.95 (-0.4%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 291.35 |
1-year : | 299.6 |
| Resists | First : | 249.44 |
Second : | 256.51 |
| Pivot price | 244.39 |
|||
| Supports | First : | 238.02 |
Second : | 198.03 |
| MAs | MA(5) : | 240.66 |
MA(20) : | 246.14 |
| MA(100) : | 238.99  |
MA(250) : | 223.85 |
|
| MACD | MACD : | -2.6 |
Signal : | -1.7 |
| %K %D | K(14,3) : | 12.1 |
D(3) : | 10.8 |
| RSI | RSI(14): 37.7 |
|||
| 52-week | High : | 259 | Low : | 182.08 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ DHR ] has closed above bottom band by 14.1%. Bollinger Bands are 14.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 241.52 - 242.86 | 242.86 - 243.95 |
| Low: | 233.82 - 235.74 | 235.74 - 237.31 |
| Close: | 236.57 - 239.41 | 239.41 - 241.73 |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Wed, 17 Apr 2024
Danaher (NYSE:DHR) Upgraded to Buy by HSBC - MarketBeat
Wed, 17 Apr 2024
Mirova US LLC Has $273.42 Million Stake in Danaher Co. (NYSE:DHR) - MarketBeat
Wed, 17 Apr 2024
Danaher Corp (DHR) Upgraded to Buy from Hold - InvestorsObserver
Wed, 17 Apr 2024
The Art of Valuation: Discovering Danaher Corp's Intrinsic Value - GuruFocus.com
Tue, 16 Apr 2024
Danaher (DHR) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
Mon, 15 Apr 2024
Danaher Corp. stock falls Monday, still outperforms market - MarketWatch
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 741 (M) |
| Shares Float | 659 (M) |
| Held by Insiders | 10.7 (%) |
| Held by Institutions | 81.6 (%) |
| Shares Short | 6,350 (K) |
| Shares Short P.Month | 6,070 (K) |
| EPS | 5.63 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 72.36 |
| Profit Margin | 19.9 % |
| Operating Margin | 20.8 % |
| Return on Assets (ttm) | 3.9 % |
| Return on Equity (ttm) | 8.1 % |
| Qtrly Rev. Growth | -23.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 32.26 |
| EBITDA (p.s.) | 10.19 |
| Qtrly Earnings Growth | -51.3 % |
| Operating Cash Flow | 7,160 (M) |
| Levered Free Cash Flow | 4,860 (M) |
| PE Ratio | 42.44 |
| PEG Ratio | 4.6 |
| Price to Book value | 3.3 |
| Price to Sales | 7.42 |
| Price to Cash Flow | 24.75 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|